MedPath

Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors

Recruiting
Conditions
Liver Tumor
Interventions
Diagnostic Test: with chronic liver disease
Registration Number
NCT06524557
Lead Sponsor
Xijing Hospital
Brief Summary

To explore an effective noninvasive method for differential diagnosis of liver tumors.

Detailed Description

A retrospective study was performed to assess the performance of certain ultrasound-based parameters, in distinguishing benign from malignant with liver biopsy as the gold standard. Demographic data, clinical information and serological data were obtained from participants who were retrospectively enrolled. Receiver operating characteristic (ROC) curve analysis was conducted, including calculation of the optimal area under the ROC curve (AUC), to assess the performance of these measures in distinguishing between benign and malignant in patients with or without chronic liver disease.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria

(1) age 18-70 years; (2) liver examination performed for all patients prior to US-guided liver biopsy or surgery; (3) tumor can be visualized in conventional US; (4) largest tumor sectional area saved in DICOM format for use in later analyses; (5) a histopathological diagnosis made either from US-guided liver biopsy or surgical resection; (6) suitable routine clinical and US data obtained within 7 days of the histopathological diagnosis.

Exclusion Criteria

(1) unavailable pathological diagnosis; (2) liver metastatic tumors; (3) poor quality US images; and (4) a past history of surgical resection, percutaneous local ablation, radiation, transarterial and systemic therapies or liver transplantation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
with chronic liver diseasewith chronic liver diseasepatients with hepatitis B virus, hepatitis C virus and other chronic liver disease.
Primary Outcome Measures
NameTimeMethod
The differential diagnosis of liver tumors2018.01-2025.12

Multimodal ultrasound is of great value in the differential diagnosis of liver tumors

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Xijing Hosptial

🇨🇳

Xi'an, Xi'an, China

© Copyright 2025. All Rights Reserved by MedPath